drugset / Trial / NCT03292965

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

NCT03292965

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring

Timeline

Start
2017-09-28
Primary completion
2017-11-29
Completion
2017-11-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Neostigmine Other / unclassified 20 ug/kg
Comparator Neostigmine Other / unclassified 40 ug/kg
Comparator Neostigmine Other / unclassified 50 ug/kg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg